JHIU
ARNA

Janus Henderson Investors US’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Janus Henderson Investors US’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$24K Buy
1,625
+239
+17% +$3.54K ﹤0.01% 1151
2016
Q4 		$20K Buy
1,386
+283
+26% +$4.38K ﹤0.01% 1201
2016
Q3 		$19K Sell
1,103
-171
-13% -$2.84K ﹤0.01% 1218
2016
Q2 		$22K Buy
+1,274
New +$22.8K ﹤0.01% 1186

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Janus Henderson Investors US's ARNA Position: Q1 2017 in Review

Janus Henderson Investors US increased its Arena Pharmaceuticals Inc (ARNA) stake by 17% in Q1 2017, buying an estimated $3.54K and bringing the position to 1,625 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1151.

Janus Henderson Investors US first reported a position in ARNA in Q2 2016 and has held it in 4 quarters since. 126 funds tracked by Wall St. Rank hold ARNA as of Q1 2017.

  • Janus Henderson Investors US held 1,625 shares of Arena Pharmaceuticals Inc worth $24K as of Q1 2017.
  • Janus Henderson Investors US bought 239 Arena Pharmaceuticals Inc shares in Q1 2017, an estimated $3.54K.
  • Arena Pharmaceuticals Inc made up ﹤0.01% of Janus Henderson Investors US's portfolio in Q1 2017, its #1151 holding.
  • Janus Henderson Investors US first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and has held it in 4 quarters since.
  • 126 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.